Navigation Links
Watson Reaches Settlement with Mallinckrodt Over Exalgo(R)
Date:1/26/2012

PARSIPPANY, N.J., Jan. 26, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc.- Florida has reached a settlement with Mallinckrodt Inc. on outstanding patent litigation related to Watson's generic versions of Mallinckrodt's Exalgo® (Hydromorphone Hydrochloride Extended-Release ) tablets.  Mallinckrodt filed its lawsuit on December 10, 2010 in the United States District Court for the District of New Jersey following Watson's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its product in the 8 mg, 12 mg, and 16 mg dosage strengths.
Under terms of the settlement agreement, Mallinckrodt has granted Watson a royalty-free license to U.S. patents relating to Exalgo®.  Watson will have the right to launch its bioequivalent products on November 15, 2013.  Other details of the settlement were not disclosed.

Based on available information, Watson believes it may be a "first applicant" to file an ANDA for the generic version of Exalgo® and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-h
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Aethlon Medical, Inc. (OTCQB: AEMD), the ... infectious diseases and cancer, today announced that ... present at the SeeThruEquity 4th Annual Microcap Investor ... Medical,s presentation are as follows:Event: , SeeThruEquity 4th ... 28, 2015Time: , 8:00 a.m. Pacific Time / ...
(Date:5/26/2015)... LONDON , May 26, 2015 ... Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma ... dolutegravir 50mg, for Tentative Approval, to the Food and ... is the first ANDA for a generic version of ... Tivicay® (dolutegravir) for sale in the United ...
(Date:5/26/2015)... , May 26, 2015  Respiratory Motion, ... nd Annual Meeting of the Japanese Society ... monitoring patient respiration in hospitals miss critical early ... to patients. The findings conclude that respiratory volume ... Motion, Inc. more consistently protects patients than traditional ...
Breaking Medicine Technology:Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 2Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 3Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5
... 21, 2011  Adeona Pharmaceuticals, Inc. (NYSE Amex: ... of Directors has taken several actions to prioritize the ... field of synthetic biology. As previously announced on November ... into a worldwide exclusive channel collaboration for the development ...
... 2011  Advocates working with the disability and aged communities ... House members to help stop a Medicare change that ... by their physicians. Seven states, including ... Medicaid Services (CMS) for a prepayment review demonstration project. ...
Cached Medicine Technology:Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development 2Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development 3Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development 4Michigan Seniors and Disabled Population Face Restricted Access to Power Wheelchairs Unless Congress Stops New Medicare Program 2Michigan Seniors and Disabled Population Face Restricted Access to Power Wheelchairs Unless Congress Stops New Medicare Program 3Michigan Seniors and Disabled Population Face Restricted Access to Power Wheelchairs Unless Congress Stops New Medicare Program 4
(Date:5/26/2015)... CA (PRWEB) May 26, 2015 ... forces with MarkLogic Corporation. The alliance ensures joint ... database platform and General Networks’ expertise in building ... Networks and MarkLogic will help customers integrate, manage ... decision-making and business processes. , “Our customers are ...
(Date:5/26/2015)... May 26, 2015 The European imaging IT ... over 45% of healthcare providers plan to make purchases. ... industry report. Data collected from these participants show that speech ... takes a back seat. , “Many imaging IT vendors ... said peer60 CEO Jeremy Bikman. “This report details the European ...
(Date:5/26/2015)... WI (PRWEB) May 26, 2015 ... - Schrader is responsible for using her quality improvement ... ’s day-to-day operations. Denise also provides leadership and direction ... Mercy Hospice Care, Mercy Home Health Care and Mercy ... experience in health care administration with the last 20 ...
(Date:5/26/2015)... 26, 2015 U.S. Food and Drug ... United States are extensive and can be difficult to ... helps medical device companies comply with FDA regulations, compiled ... companies navigate FDA requirements. , 1. Start researching ... States can be a lengthy process depending on the ...
(Date:5/26/2015)... Beginning this fall, Boston University will ... Master of Social Work (MSW) program . Already available ... River Campus, the online option will be offered starting ... option is open to applicants holding an undergraduate social ... Education. Students entering the program will be granted 22 ...
Breaking Medicine News(10 mins):Health News:General Networks Corporation Announces Alliance with MarkLogic 2Health News:peer60 report: European Healthcare IT Imaging Purchases: 2015 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 3
... ... for the first time , ... Las Vegas, NV (Vocus) March 17, 2010, , , , ,Calendar Notice, , ,2011 AHR ... , www.ahrexpo.com , , ,WHAT:    ,2011 AHR EXPO® (International Air-Conditioning, Heating, Refrigerating Exposition) , ...
... , TAMPA, Fla. , March 17 ... features to enhance its acclaimed study program for the ... exams. Effective immediately, 30 animated muscle tutorials, 25 interactive study ... nationwide. These features, which include narration for auditory learners, further ...
... ... the 2nd U.S. HealthWorks Medical Symposium in Pasadena, CA featuring innovators in healthcare research ... ... for U.S. HealthWorks Medical Group participated in the 2nd U.S. HealthWorks Medical ...
... kids age 4-8 say they don,t know state laws requiring seat use , ... , , ... ... ANN ARBOR, Mich. , March 17 All ...
... A person with fibromyalgia experiences daily pain all over their body. Even something as simple as a ... a video on the "Science of Fibromyalgia" as a resource to help people understand the underlying science behind ... ... , ...
... of cancer treatment, skin care may seem like a small ... Center knew that skin issues were a constant source of ... she discovered that routine advice was rooted in myth instead ... published in the Clinical Journal of Oncology Nursing , ...
Cached Medicine News:Health News:2011 AHR EXPO Calendar Listing 2Health News:2011 AHR EXPO Calendar Listing 3Health News:2011 AHR EXPO Calendar Listing 4Health News:Massage Prep(TM) Announces New Interactive Tutorials for NCETM, NCETMB and MBLEx 2Health News:Massage Prep(TM) Announces New Interactive Tutorials for NCETM, NCETMB and MBLEx 3Health News:Massage Prep(TM) Announces New Interactive Tutorials for NCETM, NCETMB and MBLEx 4Health News:Massage Prep(TM) Announces New Interactive Tutorials for NCETM, NCETMB and MBLEx 5Health News:Massage Prep(TM) Announces New Interactive Tutorials for NCETM, NCETMB and MBLEx 6Health News:Innovative Healthcare Symposium Held By U.S. HealthWorks 2Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 2Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 3Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 4Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 5Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 6Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 7Health News:VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia 2Health News:VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia 3Health News:Nurses' research settles a common cancer concern: Skin care 2Health News:Nurses' research settles a common cancer concern: Skin care 3
Open ring design with shaft angled at 45 degrees. Blunt teeth. Round knurled handle with dull finish....
... fixate the eye during refractive ... can easily be pivoted to ... side on the eye. Ideal ... eye to increase internal pressure ...
Anodized aluminum. Durable and lightweight with built-in protection against rust. Security locks ensure against accidental opening. Silicone matting/V-strips and bumper guards hold instruments in pla...
Size: 3 x 6 inches. Depth: 1 inch. Sterilizable plastic tray with silicone matting for supporting and protecting instruments....
Medicine Products: